Clinical Trial Update: Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 extension study evaluating the safety and efficacy of enteric-coated mycophenolate sodium in kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED